Open AccessP62 Abatacept improves fatigue, activity limitation and quality of life in methotrexate-naïve patients with early RA and poor prognostic factors
Author(s) -
Santosh Kumar Jha,
René Westhovens,
J. Wollenhaupt,
J. Bathon,
B. Haraoui,
Jan C. Becker,
Allison Covucci,
T Li
Publication year - 2009
Publication title -
indian journal of rheumatology/indian journal of rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 11
eISSN - 0973-3701
pISSN - 0973-3698
DOI - 10.1016/s0973-3698(09)60080-7
Subject(s) - abatacept , medicine , tocilizumab , adalimumab , etanercept , rheumatoid arthritis , golimumab , infliximab , placebo , rheumatology , certolizumab pegol , tnf inhibitor , randomized controlled trial , rituximab , tumor necrosis factor alpha , alternative medicine , pathology , lymphoma